ORIX Growth Capital Invests in Invincea

ORIX Growth Capital, in conjunction with Comerica Bank and existing investors including Dell Ventures, New Atlantic Ventures and Harbert Ventures, announced today that it has completed a growth capital investment in Invincea, the machine learning next-generation anti-virus company with the No. 1 malware detection rate in the industry. The investment is designed to accelerate Invencia’s growth across all major industry verticals based on the success of its next-gen anti-virus security product, X by Invincea.

X by Invincea, recently evaluated by Forrester as having the highest scores possible in attack detection and prevention effectiveness criteria in The Forrester Wave™: Endpoint Security, Q4 2016 report, and consistently rated at the top in malware detection by multiple third party testing institutions, is leading the next-gen endpoint security market, significantly outperforming the traditional anti-virus and next-gen AV players. Invincea customers across healthcare, financial services, government, state, local and education are seeing the same leading performance results on their networks, stopping unknown malware, ransomware and file-less malware in its tracks.

“Endpoint security represents the frontline in the fight against cyberattackers. Breaches have become commonplace among enterprises, and employee endpoints and servers are targeted more than any other type of asset,” wrote Chris Sherman, Senior Analyst at Forrester. “The effects from these security breaches can be devastating, causing a company to lose revenue, market reputation and market competitiveness. Unfortunately, inadequate endpoint security leaves the doors wide open to a variety of attacker techniques and tools, including malware, software exploits and social engineering. Now, more than ever, it’s critical to have the right endpoint protection in place.”

“We are excited that ORIX Growth Capital and Comerica are joining our existing investors, including Dell Ventures, to provide strategic growth capital to scale the business across core verticals and markets where we are seeing significant traction for X by Invincea,” said Anup Ghosh, Invincea CEO and Founder, and Dell Founder 50 member. “X by Invincea provides the highest performing next-gen anti-virus security solution at a time when the market requires new approaches, such as deep learning algorithms, as an alternative to legacy anti-virus solutions that have failed to adequately address the cyberthreats enterprises face today. We are giving organizations a new way to protect their critical data, stop malware and ransomware, and avoid data breaches.”

“The battle against cyberattacks at the endpoint requires new approaches to security,” said Jeff Bede, Co- Head of ORIX Growth Capital. “With our investment in Invincea, we recognize its large market opportunity and novel, differentiated technology with strong customer and product validation.”

“Cybersecurity is one of the most important challenges for businesses as devastating attacks on data have become increasingly more sophisticated,” said Dylan Anderson, Relationship Manager, Comerica Bank, Technology and Life Sciences Division. “Invincea is making tremendous strides in the prevention and detection of today’s most advanced cyberattacks. Our Technology and Life Sciences team at Comerica Bank has the expertise and knowledge to help businesses such as Invincea get the capital they need to serve this rapidly growing market.”

“Without a doubt, X by Invincea has stopped potentially malicious executables that could have infected our network. The product has proven it detects the unauthorized bad stuff and stops itand that is the point. It’s the last line of defense,” said Jeremy Clough, VP Information Security Officer at Gorham Savings Bank. “Invincea offers ransomware protection with very little overhead on the endpoint. Unlike other endpoint solutions, it doesn’t slow things down. The product implementation was easy and it needs very little support by our IT staff.”

All trademarks and logos noted are property of their respective owners and no endorsement or association of or with ORIX USA or its affiliates is intended or implied.